Marilena Manea

1.6k total citations
50 papers, 1.4k citations indexed

About

Marilena Manea is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Marilena Manea has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Organic Chemistry and 11 papers in Physiology. Recurrent topics in Marilena Manea's work include Alzheimer's disease research and treatments (11 papers), Chemical Synthesis and Analysis (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Marilena Manea is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Chemical Synthesis and Analysis (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Marilena Manea collaborates with scholars based in Germany, Hungary and United States. Marilena Manea's co-authors include Gábor Mező, Michael Przybylski, Erika Orbán, Patrízia Limonta, Ferenc Hudecz, Szilvia Bősze, Peter St George‐Hyslop, JoAnne McLaurin, Amie L. Phinney and Mary E. Brown and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Marilena Manea

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marilena Manea Germany 21 746 450 281 176 160 50 1.4k
Uri S. Ladror United States 15 734 1.0× 514 1.1× 223 0.8× 53 0.3× 167 1.0× 26 1.2k
Dana Kim Reed United States 18 689 0.9× 814 1.8× 97 0.3× 38 0.2× 178 1.1× 21 1.3k
Chenbo Zeng United States 29 1.8k 2.4× 147 0.3× 287 1.0× 292 1.7× 93 0.6× 40 2.4k
Theodore Tselios Greece 25 1.0k 1.4× 69 0.2× 173 0.6× 172 1.0× 56 0.3× 95 1.9k
Peter Chase United States 24 1.2k 1.6× 151 0.3× 221 0.8× 224 1.3× 248 1.6× 68 2.0k
Paul L. Richardson United States 19 851 1.1× 297 0.7× 126 0.4× 180 1.0× 224 1.4× 44 1.4k
Stéphanie Grandemange France 23 1.4k 1.9× 307 0.7× 151 0.5× 86 0.5× 46 0.3× 54 2.0k
Hélène Barelli France 22 1.2k 1.6× 431 1.0× 312 1.1× 54 0.3× 51 0.3× 35 1.7k
Silvia Sesana Italy 19 700 0.9× 377 0.8× 110 0.4× 110 0.6× 28 0.2× 33 1.5k
Simona D’Aguanno Italy 25 1.1k 1.4× 249 0.6× 277 1.0× 81 0.5× 32 0.2× 45 1.7k

Countries citing papers authored by Marilena Manea

Since Specialization
Citations

This map shows the geographic impact of Marilena Manea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilena Manea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilena Manea more than expected).

Fields of papers citing papers by Marilena Manea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilena Manea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilena Manea. The network helps show where Marilena Manea may publish in the future.

Co-authorship network of co-authors of Marilena Manea

This figure shows the co-authorship network connecting the top 25 collaborators of Marilena Manea. A scholar is included among the top collaborators of Marilena Manea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilena Manea. Marilena Manea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lajkó, Eszter, Pál Soós, Orsolya Láng, et al.. (2018). Drug targeting to decrease cardiotoxicity – determination of the cytotoxic effect of GnRH-based conjugates containing doxorubicin, daunorubicin and methotrexate on human cardiomyocytes and endothelial cells. Beilstein Journal of Organic Chemistry. 14. 1583–1594. 13 indexed citations
2.
3.
Manea, Marilena, Marina Montagnani Marelli, Roberta M. Moretti, et al.. (2014). Targeting Hormonal Signaling Pathways in Castration Resistant Prostate Cancer. Recent Patents on Anti-Cancer Drug Discovery. 9(3). 267–285. 9 indexed citations
4.
Schreier, Verena N., Erika Orbán, Andreas Marquardt, et al.. (2014). Protein Expression Profile of HT-29 Human Colon Cancer Cells after Treatment with a Cytotoxic Daunorubicin-GnRH-III Derivative Bioconjugate. PLoS ONE. 9(4). e94041–e94041. 9 indexed citations
5.
Thurm, Franka, Cathrin Schnack, Hayrettin Tumani, et al.. (2013). Increased Levels of Antigen-Bound β-Amyloid Autoantibodies in Serum and Cerebrospinal Fluid of Alzheimer’s Disease Patients. PLoS ONE. 8(7). e68996–e68996. 47 indexed citations
6.
Schreier, Verena N., et al.. (2013). Synthesis, enzymatic stability and in vitro cytostatic effect of Daunorubicin-GnRH-III derivative dimers. Bioorganic & Medicinal Chemistry Letters. 23(7). 2145–2150. 8 indexed citations
7.
Leurs, Ulrike, Eszter Lajkó, Gábor Mező, et al.. (2012). GnRH-III based multifunctional drug delivery systems containing daunorubicin and methotrexate. European Journal of Medicinal Chemistry. 52. 173–183. 22 indexed citations
8.
Manea, Marilena, Erika Orbán, Ildikó Szabó, et al.. (2012). Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin–GnRH-III bioconjugates. European Journal of Medicinal Chemistry. 56. 155–165. 26 indexed citations
9.
Manea, Marilena, et al.. (2011). In-vivo antitumour effect of daunorubicin–GnRH-III derivative conjugates on colon carcinoma-bearing mice. Anti-Cancer Drugs. 23(1). 90–97. 18 indexed citations
10.
Mező, Gábor, et al.. (2011). Anthracycline-GnRH derivative bioconjugates with different linkages: Synthesis, in vitro drug release and cytostatic effect. Journal of Controlled Release. 156(2). 170–178. 38 indexed citations
11.
Mező, Gábor, Ildikó Szabó, István Kertész, et al.. (2010). Efficient synthesis of an (aminooxy) acetylated‐somatostatin derivative using (aminooxy)acetic acid as a ‘carbonyl capture’ reagent. Journal of Peptide Science. 17(1). 39–46. 26 indexed citations
12.
Orbán, Erika, Gábor Mező, Gabriella Csı́k, et al.. (2010). In vitro degradation and antitumor activity of oxime bond-linked daunorubicin–GnRH-III bioconjugates and DNA-binding properties of daunorubicin–amino acid metabolites. Amino Acids. 41(2). 469–483. 63 indexed citations
13.
Drochioiu, Gabi, et al.. (2009). Interaction of β-amyloid(1-40) peptide with pairs of metal ions: An electrospray ion trap mass spectrometric model study. Biophysical Chemistry. 144(1-2). 9–20. 37 indexed citations
14.
Mező, Gábor & Marilena Manea. (2009). Luteinizing hormone-releasing hormone antagonists. Expert Opinion on Therapeutic Patents. 19(12). 1771–1785. 15 indexed citations
15.
Manea, Marilena, Michael Przybylski, Ferenc Hudecz, & Gábor Mező. (2008). Design, structural, and immuno‐analytical properties of antigenic bioconjugates comprising a β‐amyloid‐plaque specific epitope. Biopolymers. 90(2). 94–104. 7 indexed citations
16.
Mező, Gábor, András Czajlik, Marilena Manea, et al.. (2007). Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives. Peptides. 28(4). 806–820. 22 indexed citations
17.
Manea, Marilena, Gábor Mező, Ferenc Hudecz, & Michael Przybylski. (2007). Mass spectrometric identification of the trypsin cleavage pathway in lysyl‐proline containing oligotuftsin peptides. Journal of Peptide Science. 13(4). 227–236. 25 indexed citations
18.
Manea, Marilena, Gábor Mező, Ferenc Hudecz, & Michael Przybylski. (2004). Polypeptide conjugates comprising a β‐amyloid plaque‐specific epitope as new vaccine structures against Alzheimer's disease. Biopolymers. 76(6). 503–511. 14 indexed citations
19.
Zirah, Séverine, Raluca Ştefănescu, Marilena Manea, et al.. (2004). Zinc binding agonist effect on the recognition of the β-amyloid (4–10) epitope by anti-β-amyloid antibodies. Biochemical and Biophysical Research Communications. 321(2). 324–328. 20 indexed citations
20.
McLaurin, JoAnne, Tian Xu, Amie L. Phinney, et al.. (2002). Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4–10 and inhibit cytotoxicity and fibrillogenesis. Nature Medicine. 8(11). 1263–1269. 359 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uri S. Ladror Breakdown of academic impact, for papers by Dana Kim Reed Breakdown of academic impact, for papers by Chenbo Zeng Breakdown of academic impact, for papers by Theodore Tselios Breakdown of academic impact, for papers by Peter Chase Breakdown of academic impact, for papers by Paul L. Richardson Breakdown of academic impact, for papers by Stéphanie Grandemange Breakdown of academic impact, for papers by Hélène Barelli Breakdown of academic impact, for papers by Silvia Sesana Breakdown of academic impact, for papers by Simona D’Aguanno
Rankless by CCL
2026